Tesfaye H, Paik JM, Zakoul H, Schmedt N, et al. Empagliflozin versus DPP4i or GLP-1RA for the risk of nephrolithiasis in patients with type 2 diabetes: Research letter from the EMPRISE cohort study. Diabetes Obes Metab 2025 Feb 28. doi: 10.1111/dom.16303.
PMID: 40019137